This topic contains a solution. Click here to go to the answer

Author Question: If you were to design an intensive action-oriented treatment to support durable change in clients ... (Read 39 times)

Coya19@aol.com

  • Hero Member
  • *****
  • Posts: 601
If you were to design an intensive action-oriented treatment to support durable change in clients with a particular problem, you would expect that:
 
  a. it would be a very good match for those in the precontemplation and contemplation stages of change, but be detrimental for those already in the action stage of change.
  b. it would help those in the contemplation stage by moving them forward to preparation and action, but be of little impact on precontemplators or those already in the action stage of change.
  c. it would be a poor match for precontemplators and most contemplators, but quite successful for those ready for action.
  d. it would help those in the contemplation or preparation stages, but be a poor match for those in the precontemplation or action stage of change.

Question 2

The most likely stage of change profile for therapy continuers is:
 
  a. precontemplation. c. preparation.
  b. contemplation. d. action.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Chelseyj.hasty

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

C

Answer to Question 2

B




Coya19@aol.com

  • Member
  • Posts: 601
Reply 2 on: Jul 30, 2018
Excellent


Dinolord

  • Member
  • Posts: 313
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The first-known contraceptive was crocodile dung, used in Egypt in 2000 BC. Condoms were also reportedly used, made of animal bladders or intestines.

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

For a complete list of videos, visit our video library